<?xml version="1.0"?>
<Articles JournalTitle="Acta Medica Iranica">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Acta Medica Iranica</JournalTitle>
      <Issn>0044-6025</Issn>
      <Volume>34</Volume>
      <Issue>3-4</Issue>
      <PubDate PubStatus="epublish">
        <Year>1996</Year>
        <Month>12</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">INFLUENCES OF THIAMINE AND/OR ASCORBIC ACID ON LEAD INTOXICATION</title>
    <FirstPage>61</FirstPage>
    <LastPage>64</LastPage>
    <AuthorList>
      <Author>
        <FirstName></FirstName>
        <LastName>M. Ghazi-Khansari</LastName>
        <affiliation locale="en_US"></affiliation>
      </Author>
      <Author>
        <FirstName></FirstName>
        <LastName>A. Hajighasemkhan</LastName>
        <affiliation locale="en_US"></affiliation>
      </Author>
      <Author>
        <FirstName></FirstName>
        <LastName>S. Ghazaie</LastName>
        <affiliation locale="en_US"></affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>09</Month>
        <Day>28</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">The effects of thiamine, ascorbic acid ami their combination an workers who are continuously exposal to lead has been investigated. In this study 60 persons in a Battery industry was selected and divided into four equal groups. Group I received placebo, group II thiamine (300 mg), group III ascorbic acid (250 mg) anil group IV thiamine (300 mg) plus ascorbic acid (250 mg) three times a day (Orally). At beginning of the study and after one month of above drug regimen; blood, urine and a questionnaire about their clinical signs were examined. 'there were no significant differences between blood anil urine lead level in all groups after treatment. Zinc protoporphyrin (zpp) level showed a significant reduction in ascorbic acid treated group (group III) as compared to pretreatment. Clinical manifestation improved in the group that received both vitamins (group IV). However, from a clinical stand point, it appears the usage of these vitamins may have a beneficial effects in lead occupational exposure.</abstract>
    <web_url>https://acta.tums.ac.ir/index.php/acta/article/view/1695</web_url>
    <pdf_url>https://acta.tums.ac.ir/index.php/acta/article/download/1695/1688</pdf_url>
  </Article>
</Articles>
